Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection

Cytokine and Growth Factor Reviews

Volumn 24, Issue 6, 2013, Pages 571-577

  Swaminathan, Sanjay ^a   Dai, Lue ^a   Lane, H Clifford ^b   Imamichi, Tomozumi ^a  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cytokines; HIV; Interleukin 27; SPTBN1; Therapy

Indexed keywords

ALPHA INTERFERON; CANCER VACCINE; CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 27 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; MESSENGER RNA; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIVIRAL ACTIVITY; CD4+ T LYMPHOCYTE; CELL COUNT; CELL TYPE; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; DRUG SCREENING; GENE INDUCTION; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE; MIXED INFECTION; MULTIPLE SCLEROSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERINE CERVIX CANCER; VIRAL TROPISM; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CYTOKINES; HIV; INTERLEUKIN-27; SPTBN1; THERAPY;

ANIMALS; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-27; RECEPTORS, INTERLEUKIN; VIRUS DISEASES;

EID: 84888307863     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2013.07.001     Document Type: Short Survey

References (56)

1. Vignali D.A., Kuchroo V.K. IL-12 family cytokines: immunological playmakers. Nature Immunology 2012, 13:722-728.
2. Jones L.L., Vignali D.A. Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily. Immunologic Research 2011, 51:5-14.
3. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002, 16:779-790.
4. Wirtz S., Becker C., Fantini M.C., Nieuwenhuis E.E., Tubbe I., Galle P.R., et al. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. Journal of Immunology 2005, 174:2814-2824.
5. Liu J., Guan X., Ma X. Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways. Journal of Experimental Medicine 2007, 204:141-152.
6. Batten M., Ghilardi N. The biology and therapeutic potential of interleukin 27. Journal of Molecular Medicine (Berlin) 2007, 85:661-672.
7. Lupardus P.J., Garcia K.C. The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12. Journal of Molecular Biology 2008, 382:931-941.
8. Beyer B.M., Ingram R., Ramanathan L., Reichert P., Le H.V., Madison V., et al. Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody. Journal of Molecular Biology 2008, 382:942-955.
9. Stumhofer J.S., Tait E.D., Quinn W.J., Hosken N., Spudy B., Goenka R., et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nature Immunology 2010, 11:1119-1126.
10. Pflanz S., Hibbert L., Mattson J., Rosales R., Vaisberg E., Bazan J.F., et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. Journal of Immunology 2004, 172:2225-2231.
11. Garbers C., Spudy B., Aparicio-Siegmund S., Waetzig G.H., Sommer J., Holscher C., et al. An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer. Journal of Biological Chemistry 2013, 288:4346-4354.
12. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
13. Yoshimura T., Takeda A., Hamano S., Miyazaki Y., Kinjyo I., Ishibashi T., et al. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. Journal of Immunology 2006, 177:5377-5385.
14. Greenwell-Wild T., Vazquez N., Jin W., Rangel Z., Munson P.J., Wahl S.M. Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood 2009, 114:1864-1874.
15. Larousserie F., Charlot P., Bardel E., Froger J., Kastelein R.A., Devergne O. Differential effects of IL-27 on human B cell subsets. Journal of Immunology 2006, 176:5890-5897.
16. Guzzo C., Che Mat N.F., Gee K. Interleukin-27 induces a STAT1/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes. Journal of Biological Chemistry 2010, 285:24404-24411.
17. Dai L., Lidie K.B., Chen Q., Adelsberger J.W., Zheng X., Huang D., et al. IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation. Journal of Experimental Medicine 2013, 11:517-534.
18. Chen Q., Swaminathan S., Yang D., Dai L., Sui H., Yang J., et al. Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway. PLoS ONE 2013, 8:e59194.
19. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T.W., et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. Journal of Immunology 2003, 170:4886-4890.
20. Wojno E.D., Hunter C.A. New directions in the basic and translational biology of interleukin-27. Trends in Immunology 2012, 33:91-97.
21. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunological Reviews 2006, 212:28-50.
22. Pot C., Jin H., Awasthi A., Liu S.M., Lai C.Y., Madan R., et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. Journal of Immunology 2009, 183:797-801.
23. Apetoh L., Quintana F.J., Pot C., Joller N., Xiao S., Kumar D., et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nature Immunology 2010, 11:854-861.
24. Sun J., Dodd H., Moser E.K., Sharma R., Braciale T.J. CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nature Immunology 2011, 12:327-334.
25. Crotty S. Follicular helper CD4 T cells (TFH). Annual Review of Immunology 2011, 29:621-663.
26. Batten M., Ramamoorthi N., Kljavin N.M., Ma C.S., Cox J.H., Dengler H.S., et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. Journal of Experimental Medicine 2010, 207:2895-2906.
27. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annual Review of Immunology 2009, 27:485-517.
28. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nature Immunology 2006, 7:929-936.
29. Kirnbauer R., Booy F., Cheng N., Lowy D.R., Schiller J.T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:12180-12184.
30. Yang R., Murillo F.M., Cui H., Blosser R., Uematsu S., Takeda K., et al. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88. Journal of Virology 2004, 78:11152-11160.
31. Garcia-Pineres A.J., Hildesheim A., Trivett M., Williams M., Wu L., Kewalramani V.N., et al. Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine. European Journal of Immunology 2006, 36:437-445.
32. Pinto L.A., Viscidi R., Harro C.D., Kemp T.J., Garcia-Pineres A.J., Trivett M., et al. Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. Virology 2006, 353:451-462.
33. Fakruddin J.M., Lempicki R.A., Gorelick R.J., Yang J., Adelsberger J.W., Garcia-Pineres A.J., et al. Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27. Blood 2007, 109:1841-1849.
34. Imamichi T., Yang J., Huang D.W., Brann T.W., Fullmer B.A., Adelsberger J.W., et al. IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages. AIDS 2008, 22:39-45.
35. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
36. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424:99-103.
37. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650.
38. Guzzo C., Jung M., Graveline A., Banfield B.W., Gee K. IL-27 increases BST-2 expression in human monocytes and T cells independently of type I IFN. Scientific Reports 2012, 2:974.
39. Van Damme N., Goff D., Katsura C., Jorgenson R.L., Mitchell R., Johnson M.C., et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252.
40. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926.
41. Guzzo C., Hopman W.M., Che Mat N.F., Wobeser W., Gee K. IL-27-induced gene expression is downregulated in HIV-infected subjects. PLoS ONE 2012, 7:e45706.
42. Murugaiyan G., Mittal A., Lopez-Diego R., Maier L.M., Anderson D.E., Weiner H.L. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. Journal of Immunology 2009, 183:2435-2443.
43. Kwon D.S., Angin M., Hongo T., Law K.M., Johnson J., Porichis F., et al. CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes. Journal of Virology 2012, 86:6586-6594.
44. Guzzo C., Hopman W.M., Che Mat N.F., Wobeser W., Gee K. Impact of HIV infection, highly active antiretroviral therapy, and hepatitis C coinfection on serum interleukin-27. AIDS 2010, 24:1371-1374.
45. He L., Zhao J., Gan Y., Chen L., He M. Upregulation of interleukin-27 expression is correlated with higher CD4+ T cell counts in treatment of naive human immunodeficiency virus-infected Chinese. Journal of AIDS and HIV Research 2011, 3:6-10.
46. Pirhonen J., Siren J., Julkunen I., Matikainen S. IFN-alpha regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages. Journal of Leukocyte Biology 2007, 82:1185-1192.
47. Liu L., Cao Z., Chen J., Li R., Cao Y., Zhu C., et al. Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling. Journal of Biological Chemistry 2012, 287:11899-11910.
48. Bender H., Wiesinger M.Y., Nordhoff C., Schoenherr C., Haan C., Ludwig S., et al. Interleukin-27 displays interferon-gamma-like functions in human hepatoma cells and hepatocytes. Hepatology 2009, 50:585-591.
49. Schoenherr C., Weiskirchen R., Haan S. Interleukin-27 acts on hepatic stellate cells and induces signal transducer and activator of transcription 1-dependent responses. Cell Communication and Signaling 2010, 8:19.
50. Frank A.C., Zhang X., Katsounas A., Bharucha J.P., Kottilil S., Imamichi T. Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus. Journal of Interferon and Cytokine Research 2010, 30:427-431.
51. Zhu C., Zhang R., Liu L., Rasool S.T., Mu Y., Sun W., et al. Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro. Clinical Immunology 2009, 131:92-97.
52. Kao J.T., Lai H.C., Tsai S.M., Lin P.C., Chuang P.H., Yu C.J., et al. Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naive hepatitis B infection patients. Liver International 2012, 32:928-936.
53. Wang H.L., Zhang H.Y., Zhai Z.L., Zhou X. The correlation between hepatitis B virus infection and IL-27. Bio-Medical Materials and Engineering 2012, 22:187-193.
54. Swaminathan S., Hu X., Zheng X., Kriga Y., Shetty J., Zhao Y., et al. Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral properties. Biochemical and Biophysical Research Communications 2013, 434:228-234.
55. Pan H.F., Tao J.H., Ye D.Q. Therapeutic potential of IL-27 in systemic lupus erythematosus. Expert Opinion on Therapeutic Targets 2010, 14:479-484.
56. Fitzgerald D.C., Rostami A. Therapeutic potential of IL-27 in multiple sclerosis?. Expert Opinion on Biological Therapy 2009, 9:149-160.